Results 101 to 110 of about 1,084 (164)

A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers. [PDF]

Cancer
Ahmed J, Janku F, Karp DD, Piha-Paul SA, Tsimberidou AM, Yap TA, Stephen B, Yang Y, Gurses S, Liu Q, Song J, Meric-Bernstam F, Naing A.   +12 more
europepmc   +1 more source

CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen. [PDF]

NPJ Breast Cancer
House NC, Chen MM, Khazaei S, Brown V, Ramsden P, Peng DH, Moore S, Yuan L, Wu R, Wang F, Luo L, Feng N, Bristow CA, Yap TA, Keyomarsi K, Marszalek JR, Ribich S, Rinne ML, Muthuswamy LB, Faia KL.   +19 more
europepmc   +1 more source

Application of Topic Modeling to Tweets as the Foundation for Health Disparity Research for COVID-19. [PDF]

Stud Health Technol Inform, 2020
Odlum M, Cho H, Broadwell P, Davis N, Patrao M, Schauer D, Bales ME, Alcantara C, Yoon S.   +8 more
europepmc   +1 more source

Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. [PDF]

Mol Cancer Ther
Nakazawa MS, Silverman IM, Rimkunas V, Veloso A, Glodzik D, Johnson A, Ohsumi TK, Patel SR, Conley AP, Roland CL, Soliman PT, Beird HC, Wu CC, Ingram DR, Lazcano R, Song D, Wani KM, Lazar AJ, Yap TA, Wang WL, Livingston JA.   +20 more
europepmc   +1 more source

The role of anhedonia symptoms in symptomatology of posttraumatic stress disorder and related functional impairments among traumatized Chinese adults. [PDF]

Eur J Psychotraumatol
Wan J, Fang R, Liu P, Bi Y, Luo S, Cao C, Wang L.   +6 more
europepmc   +1 more source

The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study. [PDF]

Br J Cancer
Yap TA, LoRusso P, Miller RE, Kristeleit R, Paulovich AG, McMorn S, Oplustil O'Connor L, Lombardi B, Marco-Casanova P, Gangl ET, Patel B, O'Connor MJ, Dean E, Zviezdin R, Plummer R.   +14 more
europepmc   +1 more source

Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast Cancer. [PDF]

Int J Radiat Oncol Biol Phys
Jacomina LE, Swanson DM, Mitchell MP, Woodward WA, Smith BD, Hoffman KE, Goodman CR, Garber HR, Sun SX, Yap TA, Meric-Bernstam F, Arzu IY, Bloom ES, Schlembach PJ, Strom EA, Stauder MC, Shaitelman SF.   +16 more
europepmc   +1 more source

[Urban prophylaxis against the cholera outbreak in Arica, Chile, 1886-1888]. [PDF]

Hist Cienc Saude Manguinhos
Zúñiga PC.
europepmc   +1 more source

PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors. [PDF]

ESMO Open
Yap TA, Choudhury AD, Hamilton E, Rosen LS, Stratton KL, Gordon MS, Schaer D, Liu L, Zhang L, Mittapalli RK, Zhong W, Soman N, Tolcher AW.   +12 more
europepmc   +1 more source